It is clear from the available literature that much of the evidence supporting treatment recommendations for uremic bleeding comes from studies performed 25–30 years ago. At that time ...
Treatments for uremic bleeding target the various factors that seem to have a role in platelet dysfunction. Interventions can exert acute (within 6 h) or delayed (within several weeks) effects ...
and an RLS severity rating scale is used to evaluate the severity of symptoms.1 Therefore, the current trial is designed to evaluate the efficacy and safety of pramipexole in patients with uremic RLS ...